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The  human  receptor for C3b  and  C4b  (C3bR) t  was  initially isolated  from 
pooled donor erythrocyte membranes (1). Although characterized as an integral 
membrane glycoprotein of ~200,000 daltons on SDS-polyacrylamide gels (1-4), 
recent studies have demonstrated that C3bR is polymorphic (5-7).  In reports 
from our laboratory,  autoradiographs of purified surface-labeled C3bR  from 
erythrocytes (E) in 33  normal donors demonstrated three distinct patterns (5). 
~70% of individuals had a single major band of -190,000  daltons (C3bR-AA), 
~3%  of individuals had a  single major band of -220,000  daltons (C3bR-BB), 
and the remaining ~27% of individuals had both major bands (C3bR-AB). Family 
studies provided evidence that  two codominant alleles regulated these major 
bands (5).  Under this model, C3bR-AB  individuals were heterozygous for the 
two alleles, A and B, and C3bR-AA or C3bR-BB individuals were homozygous 
for their respective alleles. Although the C3bR phenotype found on E was also 
present on other C3bR-bearing cells in the same individual, several cell-specific 
structural  differences were also  identified.  First,  on  polymorphonuclear cells 
(PMN), the Mr of C3bR was ~5,000 daltons greater than that on E (6). Second, 
on E, less intense minor bands co-purified with C3bR and were found ~ 15,000 
daltons above major bands on autoradiographs (5, 6). These minor bands, found 
only on E, accounted for <25% of the total C3bR. The percent represented by 
this minor band differed among individuals but was characteristic for a  given 
individual. Third, among C3bR-AB individuals, vastly different (up to 30-fold) 
amounts of either  the  ~190,000-  or  ~220,000-dalton  C3bR  molecules were 
found on E and peripheral blood leukocytes (5, 6). The factors responsible for 
this variable expression among heterozygous individuals are unknown. 
In a study from another laboratory, this same polymorphism was described in 
a larger group of 111  unrelated individuals (7).  However, as our laboratory has 
isolated C3bR from additional normal individuals we have found several novel 
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receptor  phenotypes.  These  new  C3bR  phenotypes  are  regulated  by a  third 
codominant  allele  coding  for  an  ~160,000-dalton  C3bR.  In  view  of the  low 
number of C3bR found on E in many patients with systemic lupus erythematosus 
(SLE), we have also analyzed the frequency of C3bR polymorphic variants in this 
disease (3, 8). These studies demonstrate that, although the frequency of C3bR 
phenotypes is similar in patients with SLE and normals, certain individuals with 
SLE  express  large  quantities  of this  ~160,000-dalton  C3bR  on  E.  Analysis  of 
receptor  phenotypes  in  normal  and  SLE  families  provides  evidence  that  the 
amount of each C3bR allele expressed on E in heterozygous donors is genetically 
determined. 
Materials and  Methods 
Pur~cation of Human E, PMN, and Mononuclear Cells.  E were obtained from 30 ml of 
whole blood that was collected on the day of use in 500  U  of sodium heparin (Abbott 
Laboratories, North Chicago, IL) or in 4.5 ml of citrated dextrose (Fenwal Laboratories, 
Deerfield,  IL) if the sample was to be stored  (at 4°C) before use.  The buffy coat was 
removed by centrifugation (800 g for 8 min) and the pellet was then washed four times 
with 0.01  M potassium phosphate, 0.15 M NaCI, pH. 7.4 (PBS) to obtain packed E from 
each donor.  Leukocytes were obtained on the day of use from 250  mi of whole blood 
collected in 6% dextran (Sigma Chemical Co., St. Louis, MO), 0.15 M NaCI and 2,500 U 
of heparin.  Mononuclear  cells and  PMN  were  then  separated  by the  Ficoll-Hypaque 
method (9). The pellets typically contained >98% PMN and >90% were viable by trypan 
blue exclusion. The mononuclear layer contained monocytes and lymphocytes (variable 
ratio from each donor) that were >90% viable and contained <2% PMN. 
Surface-labeling and Solubilization of Cells.  E (~5  ×  109 cells),  PMN,  or mononuclear 
cells (~2 ×  l0 s cells) were suspended in 4 ml of PBS and iodinated with 0.25 mCi of ~2~I 
(New England Nuclear, Boston, MA) by a modified lactoperoxidase method (10).  Follow- 
ing  iodination,  E  were  lysed  at  4°C  with  15  ml of distilled  H20  containing  protease 
inhibitors (2  mM phenylmethylsulfonyl fluoride, 3 mM EDTA,  1 ~M pepstatin, and 20 
mM  iodoacetamide).  After  1 min,  15  ml of 0.3  M  NaC1 with  the  same inhibitors was 
added. E stroma were then collected by centrifugation at 33,000 g for 20 rain. E stroma 
(5  ×  109 cell equivalents) and intact PMN and mononuclear cells (1  ×  l0 s) were then 
solubilized at 4°C  in  1 ml PBS,  1%  Nonidet P-40 (NP-40) in the presence of the same 
protease inhibitors used for lysis of E.  After centrifugation at 33,000 g for 20 min, the 
supernatant from each cell preparation were stored at -22°C. 
Isolation of C3bR by Affinity Chromatography or Immunoprecipitation.  Affinity chromatog- 
raphy was preformed as previously described using C3, methylamine-treated C4 (mC4), 
bovine serum albumin, or rabbit immunoglobulin G (Rig G) as affinity ligands (5). These 
ligands  were  coupled  to  Sepharose  (2B,  Sigma  Chemical  Co.)  by cyanogen  bromide. 
Methylamine-treatment of C4 cleaves the thioester bond within the a  chain of C4. This 
modification induces a conformational change in the molecule such that it is functionally 
similar to C4b (11).  Use of C3-Sepharose or C3b-Sepharose as iigands produce identical 
results and C3-Sepharose has been previously used to isolate C3bR (1-3, 5). Apparently, 
in the process of coupling C3 to Sepharose beads the thioester bond in C3 is disrupted 
and a C3b-like site is exposed. 
2  ml  of solubilized  labeled  preparations  from E,  PMN,  or  mononuclear cells  were 
incubated  for  30  min  at  room  temperature  with  0.4  ml  of BSA-Sepharose and  then 
centrifuged at  300  g  ×  5  rain.  The  solubilized  preparations were  then  removed and 
diluted with 4 ml of distilled H20, 1% NP-40 before transfer to 0.4 ml of C3-Sepharose, 
mC4-Sepharose, or Rig G-Sepharose. After a 1-h incubation at room temperature, samples 
were then centrifuged (300 g for 5 min). The beads were transferred to 0.7 × 4 cm plastic 
columns  (Bio-Rad  Laboratories,  Richmond,  CA)  with  6  ml of borate  buffer (65  mM 
sodium borate, 50 mM NaC1, pH 8.0),  1% NP-40. Columns were rinsed with 4 ml of the DYKMAN ET AL.  693 
same buffer and eluted with 4 ml of 0.4 M NaCi,  1% NP-40. Eluates were then dialyzed 
against water at 4°C and precipitated with acetone to remove residual NP-40.  Before 
application to gels, samples were placed in 80 #1 of loading buffer that contained 0.25 M 
Tris-HC1, 2% SDS,  10% (wt/vol) glycerol, 0.001% bromphenol blue, pH 6.8. 
For immunoprecipitation a mouse monoclonal IgG 1 antibody (57F) against erythrocyte 
C3bR was utilized (3). This antibody was graciously provided by Victor Nussensweig, New 
York  University  Medical  Center,  New  York.  Purified membranes  from Staphylococcus 
aureus,  Cowan  I  strain  (SaCI)  were  prepared  as  previously  reported  for  use  as  an 
immunoadsorbent (12). Solubilized preparations (0.5 ml) from E, PMN, or mononuclear 
cells were incubated for 15 min with 0.05 ml SaCI and the SaCI was then removed by 
centrifugation (2,000 g for 5 min). The supernatant was then added to 0.02 ml of a 1:100 
dilution of ascitic fluid containing 57F or an  equal concentration of a  control mouse 
monoclonal of  the same subclass as 57F (provided by  Joseph Davie, Washington University, 
St. Louis, MO). After 1 h, 0.02 ml of 1:100 dilution of a rabbit antimouse antibody was 
added (Dako Corp., Santa Barbara, CA).  1 h later, the preparations were transferred to 
0.05 ml of SaCI. The SaCI pellets were then washed four times in 1 ml of PBS, 1% NP- 
40 at 4°C. The proteins bound to the SaCI were removed by resuspending the pellet in 
80 #1 of loading buffer (see above) and heating at 80°C for 5 min. After centrifugation, 
the supernatant was loaded on gels for analysis.  In some experiments, a rabbit polyclonal 
antibody against C3bR  (gift of Victor Nussensweig) was  utilized rather than  57F.  No 
second antibody was added in these experiments. 
SDS-Polyacrylamide Gel Electrophoresis.  Slab gel electrophoresis was performed accord- 
ing to the method of Laemmli (13), using a  5% or a  6-18% polyacrylamide gradient. 
Samples for either type of gel were loaded on a 3% stacking gel. For reduced gels, samples 
in loading buffer were treated in the dark at 37°C with 20 mM dithiothreitol for 30 min 
and then  50  mM  iodoacetamide for  1 h.  Autoradiographic techniques and  molecular 
weight markers have been previously described (5). A Quick Scan  Jr. densitometer (Helena 
Laboratories, Beaumont, TX) was used to quantitate the relatively intensity of autoradi- 
ographic bands. In some experiments, receptor was run on SDS-polyacrylamide gels and 
stained by silver nitrate (14). 
Selection of  Patients with SLE.  All patients with SLE were randomly selected from clinics 
at Washington  University School of Medicine and fulfilled at least four of the revised 
criteria for the diagnosis of SLE (15). Among 45 patients there were 4  males and 41 
females ranging in age from 19 to 63 years (mean, 37 years). At the time of study, 37 of 
the 45 patients were on oral prednisone and 21  of these 37  patients had evidence of 
disease activity. 
Statistical Methods.  Potential differences in C3bR phenotype frequencies among indi- 
viduals were evaluated by Chi-squared testing of contingency tables with Yate's correction 
(16). A Student's t-test for unpaired data was used for comparison of densitometric data 
among individuals. 
Results 
Ident~cation  of Novel  C3bR  Phenotypes.  Autoradiographs  of immunoprecipi- 
tated ~5I surface-labeled C3bR obtained from E in five selected normal donors 
are shown in  Fig.  1.  Immunoprecipitation  using a  mouse monoclonal antibody 
against C3bR (57F) demonstrates two major bands at ~190,000 and ~220,000 
daltons in the first individual (track I). This individual is heterozygous for the A 
and B alleles (C3bR-AB) that determine two structurally distinct C3bR-molecules 
(5-7).  In  the  adjacent  track,  a  second  individual  had  a  single  major  band  of 
~190,000  daltons.  This individual  is homozygous for the  A  allele (C3bR-AA) 
determining  the  ~190,000-dalton  C3bR  (5-7).  A  third  previously  described 
phenotype (not shown here) consists of a single major band of -220,000 daltons 
(C3bR-BB).  Individuals  with  this  phenotype are  homozygous  for  the  B  allele 694  POLYMORPHISM  OF  THE  HUMAN C3b/C4b  RECEPTOR 
FIGURE  1.  Erythrocytes from five normal individuals were surface-labeled with ~25I, solubi- 
lized and  immunoprecipitated with monoclonal antibody (57F) against C3bR (tracks 1-5). 
Control immunoprecipitations with a monoclonal antibody with no known specificity  (C) were 
performed in parallel on labeled preparations in the individuals  in tracks 4 and 5 (tracks 6 and 
7). Autoradiographs of two 5% nonreduced gels are shown. 
determining  the  ~220,000-dalton  C3bR  (5-7).  Faint  bands  seen  on  autoradi- 
ographs above the ~190,000  band (tracks 2  and 4) or above the 220,000  band 
(track  1) represent minor bands.  These less intense  or minor bands  have been 
noted previously in  normal  individuals  and are  not inherited  in  a  codominant 
fashion as are the ~ 190,000-and ~220,000-C3bR molecules (5, 6). 
In  track 3  immunoprecipitation of C3bR  in a  third individual  demonstrated 
the -  190,000-dalton  C3bR  and an additional  band at  ~ 160,000  daltons.  This 
pattern has been reproducibly observed in this donor on five separate occasions 
over a  6-month  period.  Scanning  densitometry of these  five autoradiographs 
indicated that between 20 and 25% of the total radioactivity was in the ~160,000- 
dalton band. Identical results are also obtained when a polyclonal rabbit antibody 
against  C3bR  is  utilized for immunoprecipitation  (not shown).  Two additional 
individuals with an ~160,000-dalton  molecule are shown in tracks 4 and 5. The 
individuals in  tracks 3  and  4  have similar receptor phenotypes.  The individual 
in track 5, however, demonstrates that the 160,000-dalton molecule may also be 
found  with  the  -220,000-dalton  C3bR.  Of  note  is  that  in  this  donor  the 
~160,000-  and  ~220,000-dalton  bands  are  of  equal  intensity.  (By  scanning 
densitometry, ~50%  of the radioactivity is present in the ~ 160,000 band). This 
healthy individual is the daughter of a  patient with SLE, and patients with SLE 
as well as some family members have relatively large amounts of the ~ 160,000- 
dalton  molecule on E  (see below).  10  individuals  (5  males and  5  females) with 
this ~ 160,000-dalton band on E have been identified. 
Immunoprecipitations  were also performed in  parallel with a  control  mouse 
monoclonal antibody on individuals in tracks 4 and 5. This nonspecific antibody 
has  the same  subclass  as  the antibody against  C3bR  and  was  used at  the  same 
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not precipitated by this nonspecific antibody (tracks 6 and  7). To evaluate the 
possibility  that  the  ~160,000-dalton  molecule  was  a  proteolytic  breakdown 
product of the larger ~190,000-or ~220,O00-dalton molecules, mixing experi- 
ments were performed. In these experiments, labeled E from donors with CBbR- 
AA or C3bR-BB were mixed with unlabeled E from a donor with the ~160,000- 
dalton molecule. In  both cases,  no ~160,000-dalton  molecule was isolated by 
immunoprecipitation from the C3bR-AA or C3bR-BB donors (not shown). 
In Fig.  2, C3bR was immunoprecipitated from a previously identified C3bR- 
AB normal individual (track 1) and three selected patients with SLE (tracks 2- 
4). The first patient (track 2) has a faint major band at ~220,000  daltons and a 
predominant major band at ~ 160,000 daltons. The second patient has a typical 
C3bR-AA phenotype (track 3) and the last patient has a major band at ~ 190,000 
daltons that aligns with the AA phenotype in track 3 and a predominant major 
band at ~ 160,000 daltons. In the two patients with SLE, scanning densitometry 
demonstrates the ~ 160,000-dalton band contains ~85% of the total radioactivity 
in the receptor. Of interest is the band below the ~ 190,000-dalton  major band 
in  track  4  (arrow  head).  We  have  only found  this  band  in  donors  with  the 
~160,000-dalton  molecule. A  similar Mr band  is also  faintly visualized in  the 
patient in track 2.  Since it co-purifies with C3bR by immunoprecipitation, this 
band  probably  represents a  minor band  associated  with  the  ~160,000-dalton 
major band. 
In previous  reports,  phenotypes expressed on  E  were also  found on  other 
C3bR  bearing  peripheral  blood  leukocytes (6,  7).  To  assess  this  finding  in 
individuals with the ~160,000-dalton  molecule, C3bR was purified by affinity 
chromatography from E  and Ficoll-Hypaque-purified PMN and mononuclear 
cells in  two normal individuals with the ~160,000-dalton  molecule. Results in 
both  individuals  were  similar and  a  representative autoradiograph  of eluates 
obtained by C3-Sepharose from one of these individuals is shown in Fig.  3.  In 
track 1, eluates obtained from E demonstrate a single major band at ~190,000 
daitons, a  major band at ~160,000  daltons, and a  faint minor band above the 
FIGURE 2.  Erythrocytes from one normal individual (track I) and three individuals with SLE 
(tracks 2-4) were surface-labeled with l~sI and solubilized, and C3bR was purified by immu- 
noprecipitation.  A  single 5%  nonreduced  gel was  subjected  to autoradiography.  The  faint 
high Mr bands seen above 260,000 daltons in track 3 do not appear regularly on immunopre- 
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FIGURE 3.  Peripheral  blood cells from a single donor were surface-labeled  with tlsI, solubi- 
lized, and subjected to affinity  chromatography  with C3-Sepharose (tracks 1-3) or Rig G- 
Sepharose (tracks 4-6). An autoradiograph  of a 5% nonreduced  gel is shown for E in tracks 1 
and 4, for PMN in tracks 2 and 5 and for unseparated mononuclear  cells in tracks 3 and 6. 
190,000-dahon major band. In PMN from this same donor, two bands are also 
found. However, these bands are ~5,000 daltons greater than the ~ 190,000- or 
~ 160,000-dalton major bands on E (track 2). On unseparated mononuclear cells 
two bands are also  found (track 3).  These  bands more closely align with the 
~ 160,000- and -190,000-dahon major bands on E. Similar results are obtained 
when C3bR is purified from peripheral blood cells by immunoprecipitation or 
by affinity chromatography with mC4-Sepharose (not shown). 
Affinity chromatography was  performed with RIgG-Sepharose as a  control 
ligand in parallel on the preparations shown in tracks 1-3. No molecules corre- 
sponding to  C3bR  were  isolated.  C3bR  autoradiographic patterns on  6-18% 
gradient gels (not shown) are similar to those on 5% gels; however, the small Mr 
difference between C3bR on PMN and C3bR on mononuclear or  E is not as 
readily apparent on gradient gels. If samples are reduced with dithiothreitoi and 
alkylated with iodoacetamide before electrophoresis, there is an ~30,000-dahon 
increase in the apparent Mr of the molecules but no change in the band pattern. 
This effect of reducing conditions on the apparent Mr of C3bR has been noted 
previously (5). 
Population Studies in Normal Individuals and Patients with SLE.  To evaluate the 
frequency of the -160,000-dahon molecule, C3bR phenotypes in 104 unrelated 
normal individuals were analyzed. As shown in Table I, homozygous C3bR-AA 
individuals were most common with 72 of 104 (69.2%) possessing this phenotype. 
The heterozygous C3bR-AB phenotype was found in 25 of the 104 individuals 
(24.0%).  There were four (3.8%) homozygous C3bR-BB individuals and three 
(2.9%)  individuals with  both  the  -190,000-  and  ~160,000-dahon  molecules 
(C3bR-AC).  Although  a  single  normal  individual  with  the  ~220,000-  and 
160,000-dahon molecules (C3bR-BC) is shown in Fig. 1, this individual, found 
in  family studies  (detailed  below),  is  not  included  in  this  table  of unrelated 
donors. No individual with only the ~160,000-dalton molecule (C3bR-CC) has DYKMAN  ET  AL.  697 
been found. 
Since the ~ 160,000-dalton molecule (a) co-purifies with other C3bR molecules 
by affinity chromatography or immunoprecipitation, (b) is found on E with either 
the  ~190,000-  or  ~220,000-dalton  C3bR,  and  (c)  is  present  on  other  C3bR 
bearing peripheral blood cells, it seemed likely that the ~160,000-dalton  mole- 
cule represented a third codominant C3bR allele. Under this model, the expected 
frequencies for C3bR phenotypes were calculated based upon Hardy-Weinberg 
equilibria for three codominant alleles at a singl  e locus (Table I). As can be seen, 
the observed phenotype frequencies closely agree with the expected frequencies 
(X  2 =  0.06,  p  >  0.9).  Of note  is  that  individuals with  the  C3bR-BC  or  -CC 
phenotypes would be so uncommon (1  of 333 or 1 of 10,000, respectively) that 
screening of a  much larger number of individuals would be  necessary to find 
these phenotypes in unrelated donors. The calculated gene frequencies for the 
three alleles in the 104 individuals are shown in Table I. Gene frequencies were 
also evaluated among races in  the  104  normal individuals.  For  37  blacks,  the 
gene frequencies were A =  0.78, B =  0.20 and C =  0.01. For 67 Caucasians the 
gene frequencies were A  =  0.86, B =  0.13, and C =  0.01. The three remaining 
patients were  Oriental  and were all  C3bR-AA.  The  differences among blacks 
and Caucasians were not significantly different (×~ =  2.21, p >  0.3). 
In 45 patients with SLE, the frequency of different receptor phenotypes on E 
was not significantly different from that in normal individuals (×2 =  0.41, p  > 
0.9,  Table  II).  However,  in  the  three  patients  with  SLE  who  expressed  the 
~160,000-dalton  C3bR  on E, autoradiographs of C3bR  demonstrated a  much 
greater  quantity of the  ~160,000-dalton  molecule than that found in normal 
TABLE  I 
Frequency of C3bR Phenotypes in 104 Unrelated Normal Individuals 
C3bR-  Observed  Expected 
phenotype  M, x  10 -3 
No. (%)  Genotype  % 
AA  190  72 (69.2)  AA  68.9 
AB  190/220  25 (24.0)  AB  26.6 
BB  220  4 (3.8)  BB  2.6 
AC  190/160  3 (2.9)  AC  1.7 
BC  220/160  0 (0)  BC  0.3 
cc  16o  o (o)  cc  O.Ol 
Gene frequency: A -- 0.83, B -- 0.16, and C =  0.01. 
TABLE  II 
Analysis of C3bR Phenotypes in Patients with SLE 
C3bR phenotype  SLE  Normal 
No. (%)  No. (%) 
AA  28 (62)  72 (69) 
AB  12 (27)  25 (24) 
BB  2 (4.4)  4 (3.8) 
AC  2 (4.4)  3 (2.9) 
BC  1 (2.2)  0 (0) 
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individuals.  By  scanning densitometry, the  ~160,000-dalton  molecule in  the 
three SLE patients contained 48,  85, and 85%  of the total radioactivity in the 
receptor  (see  Fig.  2).  In  contrast,  in  the  three  unrelated  C3bR-AC  normal 
individuals the ~160,000 band possessed 15,  20, and 22% of the total radioac- 
tivity in  the  receptor.  In  the  25  unrelated normal  C3bR-AB  individuals, the 
mean intensity of the ~190,000 band was 57.7 +_ 4.0% (mean +  SEM). This was 
not significantly different than the mean intensity of the ~ 190,000 band in the 
12 C3bR-AB patients with SLE (63.3 _+ 5.8%, t =  0.81, p >  0.4). 
To further evaluate the inheritance of C3bR phenotypes, children from  16 
normal  families and  2  SLE  families were  studied  (Table  III).  These  studies 
demonstrate that  the  three  C3bR  molecules were  inherited in  a  codominant 
fashion at a single locus. Homozygous parents for the A allele (AA x  AA) have 
only homozygous children (AA), and parents that are each homozygous for one 
of the A or B alleles (AA x  BB) have only heterozygous offspring (AB). If either 
parent is heterozygous for different alleles (AA x  AB or AA x  AC) the expected 
equal  number  of homozygous (AA)  and  heterozygous children  (AB  or  AC, 
respectively) are found. Finally, in parental pairings in which all three alleles are 
present (AB x  AC, AB x  BC)  only offspring with the expected genotypes are 
found. In no case did any individual express more than two of the three alleles. 
Variable Amount of Different  C3bR Molecules on Autoradiographs  in Heterozygous 
Siblings.  Unrelated C3bR-AB normal individuals may express markedly differ- 
ent amounts of the 190,000 and 220,000 molecules on E (5-7). Among unrelated 
C3bR-AB normal individuals and patients with SLE, the quantity of radioactivity 
in the -190,000-dalton major band on E as determined by densitometry of the 
autoradiograph varied from 17 to 90% of the total radioactivity in both bands. 
In five unrelated C3bR-AC normal individuals and patients with SLE, the amount 
of radioactivity in the ~190,000-dalton major band on E also varied extensively 
from  15  to  85%.  Although  there  is  variability among heterozygous donors, 
repeat isolation of C3bR in the same heterozygous donor gives a similar percent 
of radioactivity in each band (6). Furthermore, silver staining of unlabeled C3bR 
from  selected  heterozygous  individuals  on  gels  also  demonstrates  a  similar 
proportion of major bands as those found on autoradiographs of surface-labeled 
C3bR (not shown). To evaluate whether variable expression of C3bR molecules 
in  heterozygous individuals is  inherited,  densitometric  scanning of autoradi- 
ographs  of  C3bR  on  E  in  related  heterozygous siblings  in  10  families  was 
performed  (Table  IV).  In  contrast  to  the  considerable  variability among all 
TABLE  III 
Inheritance of C3bR Phenotypes in 18 Families 
Phenotypes  of 
parents 
Phenotypes of children 
AA  BB  CC  AB  AC  BC 
AA x AA  21  0  0  0  0  0 
AA × BB  0  0  0  7  0  0 
AA x AB  19  0  0  18  0  0 
AA x AC  2  0  0  0  2  0 
AB x AC  0  0  0  0  2  1 
AB x BC  0  1  0  1  2  0 DYKMAN  ET  AL.  699 
TABLE  IV 
Phenotypic Expression of C3bR Among Heterozygous Siblings 
Family  C3bR phenotype  C3bR in MT --190,000 band* 
% 
1  AB  73, 72, 70, 68, 61 
2  AB  63, 61, 60 
3  AB  90, 86 
4  AB  62, 61 
5  AB  80, 71 
6  AB  60, 56 
7  AB  79, 76, 70 
8  AC  22,  14 
9  AC  82, 81 
10  AC  85, 78 
* Percent determined by densitometric scanning  of 
C3bR-AB or C3bR-AC siblings. 
autoradiographs  in 
unrelated  heterozygous donors,  heterozygous siblings have similar proportions 
of the  two C3bR molecules.  There  is <15%  difference in  the amount  of the 
-190,000-dalton  C3bR among heterozygous siblings in any given kindred.  Of 
interest is that of the two siblings who possess large amounts of the ~160,000- 
dalton molecule (kindred 8), a female has SLE (shown in Fig. 2, track 4) and her 
brother is healthy at the age of 58. 
Discussion 
Previous  studies  demonstrated  that  two  codominant  alleles  regulated  poly- 
morphism of C3bR on human peripheral blood cells (5-7). In this report, normal 
individuals  and  patients  with  SLE  were  found  to  have  an  ~160,000-dalton 
molecule on E  that  co-purified with two previously reported  C3bR molecules. 
Several lines of evidence indicate that  this ~160,000-dalton  molecule is C3bR. 
First,  the molecule was immunoprecipitated  by monoclonal  or polyclonal anti- 
bodies against C3bR. Second, the ~ 160,000-dalton molecule was isolated by C3- 
or  mC4-Sepharose  affinity  chromatography.  Third,  in  individuals  with  the 
160,000-dalton molecule on E, a similar receptor phenotype was also expressed 
on other  C3bR-bearing  leukocytes.  Indeed,  donors  with  the  ~160,000-dalton 
molecule on E demonstrated an ~5,000-dalton increase in the M~ of this molecule 
on PMN (Fig.  2).  This Mr increase is identical to that reported for other C3bR 
molecules on PMN (7). 
Two previous studies failed to identify this ~160,000-dalton  C3bR molecule. 
The first study by our laboratory evaluated 33 unrelated normal individuals and 
was  probably  too  small  a  sample  to  identify  individuals  with  the  uncommon 
160,000-dalton C3bR (5). However, a second report by another laboratory in 
a  larger  group  of  111  unrelated  normal  individuals  also failed  to  detect  this 
molecule (7).  In this study silver nitrate staining of SDS-polyacrylamide gels was 
used to screen most donors. Examination of published gels using this methodol- 
ogy demonstrate heavy background staining in the ~ 160,000-dalton range, which 
could have prevented  identification  of the ~160,000  C3bR. Furthermore,  the 
amount of the ~ 160,000 C3bR on E in normal heterozygous individuals is small. 700  POLYMORPHISM  OF  THE  HUMAN  C3b/C4b  RECEPTOR 
All three of the  unrelated  normal  individuals  with  the  ~160,000-dalton  C3bR 
have less than  ~25%  of the total C3bR in this band on autoradiographs.  Only 
patients with SLE or their relatives have a large amount of the ~ 160,000-dalton 
C3bR  and  these  individuals  were  not  examined  in  the  second  study.  The 
-160,000-dalton  molecule  does  not  represent  a  proteolytic  fragment  of the 
larger ~ 190,000- or ~220,000-dalton  C3bR molecules. It is reproducibly found 
in only certain  individuals,  the quantity of the molecule is constant  in a  given 
individual, and it is found on all cell types that possess C3bR. Mixing experiments 
failed to disclose production of the ~ 160,000-dahon molecule from donors with 
the other two alleles. Finally, the ~ 160,000-dalton C3bR is inherited. 
Family studies demonstrate that three codominant alleles at a single locus are 
responsible  for  C3bR  phenotypes.  None  of the  225  individuals  in  this  study 
expressed more than two of the three C3bR molecules. The frequencies of C3bR 
phenotypes observed in  104  unrelated  normal  individuals  are also compatible 
with Hardy-Weinberg equilibria for this model. We have chosen to designate the 
three  alleles  as  A,  B,  C  in  order  of decreasing  gene  frequency.  In  normal 
individuals,  the most common allele (A) determines the ~ 190,000-dalton C3bR 
molecule and has a gene frequency of 0.83. The second allele (B) determines the 
~220,000-dalton  C3bR molecule and has a  gene frequency of 0.16.  The third 
allele  (C)  determines  the  ~160,000-dalton  C3bR  molecule  and  has  a  gene 
frequency of 0.01.  There  were  no  major  differences in  gene  frequencies  for 
these three alleles between blacks and Caucasians or between patients with SLE 
and normals.  However, since the gene frequencies for each population were not 
identical,  it  is  possible  that  small  differences  in  gene  frequencies  would  be 
demonstrated if a larger number of individuals had been surveyed (i.e., a higher 
frequency of the B allele in the black population). 
In  individuals  who are  heterozygous (C3bR-AB, C3bR-AC),  scanning  densi- 
tometry of the autoradiograph  demonstrated a  large difference in the quantity 
of radioactivity in each C3bR band. It is quite unlikely that this difference reflects 
variable surface-labeling of C3bR molecules. This would require similar mole- 
cules on different donors to label with greatly different efficiency. Furthermore, 
silver staining of gels with receptor purified from selected heterozygous donors 
demonstrates that the amount of different C3bR molecules visualized by silver 
staining is similar to that seen on autoradiographs of 125I surface-label receptors 
(reference 7, this paper). Therefore, among unrelated heterozygous donors any 
one of the three C3bR molecules may be preferentially expressed. In C3bR-AB 
individuals,  the  quantity of the  ~190,000-dalton  molecule on E  was similar in 
patients with SLE and normals. However, in C3bR-AC individuals a much greater 
amount  of  the  ~160,000-dalton  molecule  was  found  in  patients  with  SLE 
compared with that in normal individuals.  It is unlikely this finding is acquired 
since the healthy brother of a  patient with SLE also had a  large amount of the 
~  160,000-dalton  C3bR on E. Furthermore,  heterozygous siblings (C3bR-AB or 
C3bR-AC) in  nine  other  families  had  a  similar  proportion  of different  C3bR 
molecules on E. These findings strongly suggest that an inherited factor controls 
the expression of these different C3bR molecules. Except for the greater expres- 
sion of the ~160,000-dalton  C3bR in a small number of patients with SLE (3 of 
45),  no  major  differences  in  C3bR  phenotypes  were  found  among  normal DYKMAN  ET  AL.  701 
individuals and patients with SLE. Thus, C3bR polymorphism is unlikely to be 
important  in  the  majority  of patients  with  SLE.  Nevertheless,  these  results 
identify a novel C3bR phenotype that appears to be associated with SLE. 
The large difference in the Mr among the polymorphic forms of C3bR raises 
important questions regarding the molecular basis for this polymorphism. Al- 
though glycoproteins may exhibit anomalous migration when Mr is characterized 
on SDS-polyacrylamide gels, a 60,000-dalton difference in Mr among alleles is a 
unique observation. Most polymorphic variants of serum proteins are found by 
isoelectric focusing and represent charge differences (17). However, previously 
characterized allelic variants of murine C4 demonstrate an ~5,000 difference in 
Mr by SDS-polyacrylamide gels (18,  19).  In this case, the uncommon allele was 
approximately one-third as hemolytically efficient as the common allele (19, 20). 
To date, the C3bR-AA and C3bR-BB phenotypes have been found to bind both 
C3 and C4 (5) and to be equally efficient in the C3b inactivator-mediated cleavage 
of C3b (21).  Evaluation of the functional capacities of the AC phenotype is in 
progress.  In the allelic variants of murine C4, a  variation in carbohydrate was 
found to account for the Mr difference on gels (19). Although evidence indicates 
that N-linked carbohydrates do not account for the Mr difference between the 
~ 190,000- and ~220,000-dalton C3bR (7),  the contribution of O-linked carbo- 
hydrates of C3bR Mr is unknown. Recently, O-linked carbohydrates have been 
demonstrated to account for -40,000  daltons of the apparent Mr of the LDL 
receptor  ~ and HSV1 glycoprotein (22). Further carbohydrate as well as peptide 
studies are needed to ascertain the structural basis for the apparent Mr differences 
in these polymorphic forms of C3bR. 
In summary, further analysis of the C3b/C4b receptor in normal individuals 
and patients  with  SLE has proven  to  be  instructive.  Some  of the  interesting 
features of this integral membrane glycoprotein include: (a) three alleles coding 
for polymorphic variants with  relatively large Mr differences, (b)  several cell- 
specific structural variations, (c) variable but genetically regulated gene product 
expression  among  heterozygotes,  and  (d)  an  apparent  association  between  a 
certain C3bR phenotype and SLE. Studies to elucidate the molecular basis and 
functional consequences of these observations are in progress. 
Summary 
We  have  isolated  C3bR  from  surface-labeled  erythrocytes of  180  normal 
individuals and 45 patients with SLE. These studies have identified a previously 
unrecognized C3bR molecule on E with a Mr of-160,000 daltons on nonreduced 
SDS-polyacrylamide gels. A  similar receptor phenotype is also found on other 
C3bR-bearing peripheral blood leukocytes. Family studies demonstrate that this 
~ 160,000-dalton molecule represents a third allele that is inherited in a codom- 
inant fashion at the same locus as the two previously described C3bR alleles. In 
unrelated normal donors a  common allele (A) determines an -190,000-dalton 
C3bR (gene frequency 0.83), a second allele (B) determines an ~220,000-dalton 
C3bR  (gene  frequency  =  0.16),  and  a  third  rare  allele  (C)  determines  an 
Cummings,  R.,  S.  Kornfeld,, W. Schneider, K.  Hobgood, H.  Tolleshauq, M.  Brown, and J. 
Goldstein. Biosynthesis  of the  N- and  O-linked oligosaccharides of the  low  density lipoprotein 
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-160,000-dalton  C3bR (gene frequency =  0.01).  There were no major differ- 
ences in gene frequencies among Caucasians and blacks or normal individuals 
and patients with SLE. However, compared with normal individuals, heterozy- 
gous C3bR-AC patients with SLE express large amounts of the ~ 160,000-dalton 
C3bR  on  E.  Expression  of C3bR  molecules  among  heterozygous  siblings  is 
similar, suggesting that an inherited factor controls expression of the two mole- 
cules in heterozygous donors.  These  observations constitute an instructive ex- 
ample of a  structural polymorphism of an integral membrane glycoprotein and 
provide  a  structural  and  genetic  basis  for  further  molecular  and  functional 
analyses of C3bR in normal and patient populations. 
We thank Miss Peggy Finan for secretarial assistance,  Mr. Jerry Turner  for technical 
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reviews of this manuscript. 
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